BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37814187)

  • 1. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
    Shelton C; Ruiz A; Shelton L; Montgomery H; Freas K; Ellsworth RE; Poll S; Pineda-Alvarez D; Heald B; Esplin ED; Nielsen SM
    Ann Surg Oncol; 2024 Jan; 31(1):325-334. PubMed ID: 37814187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study.
    Abdel-Razeq H; Sharaf B; Bani Hani H; Abu Hijlih R; Alkyam M; Al-Azzam K; Elemian S; Tbakhi A; Al-Atary A; Ellsworth RE; Russell EM; Esplin ED; Horani M; Zeidan Z; Alzibdeh A; Heald B; Nielsen SM; Nussbaum RL
    JCO Glob Oncol; 2024 Jun; 10():e2400068. PubMed ID: 38843472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
    Whitworth PW; Beitsch PD; Patel R; Rosen B; Compagnoni G; Baron PL; Simmons R; Brown EA; Gold L; Holmes D; Smith LA; Kinney M; Grady I; Clark P; Barbosa K; Lyons S; Riley L; Coomer C; Curcio L; Ruiz A; Khan S; MacDonald H; Hughes K; Hardwick MK; Heald B; Munro SB; Nielsen SM; Esplin ED
    JAMA Netw Open; 2022 Sep; 5(9):e2232787. PubMed ID: 36136330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of Pathogenic Germline Variants in Patients With Lung Cancer.
    Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study.
    Nacer DF; Vallon-Christersson J; Nordborg N; Ehrencrona H; Kvist A; Borg Å; Staaf J
    Genome Med; 2023 Apr; 15(1):25. PubMed ID: 37060015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
    Samadder NJ; Riegert-Johnson D; Boardman L; Rhodes D; Wick M; Okuno S; Kunze KL; Golafshar M; Uson PLS; Mountjoy L; Ertz-Archambault N; Patel N; Rodriguez EA; Lizaola-Mayo B; Lehrer M; Thorpe CS; Yu NY; Esplin ED; Nussbaum RL; Sharp RR; Azevedo C; Klint M; Hager M; Macklin-Mantia S; Bryce AH; Bekaii-Saab TS; Sekulic A; Stewart AK
    JAMA Oncol; 2021 Feb; 7(2):230-237. PubMed ID: 33126242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multi-Site Single-Institution Prospective Study.
    Choudry MM; Durant AM; Edmonds VS; Warren CJ; Kunze KL; Golafshar MA; Nielsen SM; Esplin ED; Andrews JR; Samadder NJ; Tyson MD
    J Urol; 2024 Jun; ():101097JU0000000000004089. PubMed ID: 38860938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.
    Acevedo F; Walbaum B; Camus M; Manzor M; Muñiz S; Medina L; Petric M; Reyes P; Domínguez F; Puschel K; Merino T; Bravo ML; Pinto MP; Ibáñez C; Hughes K; Sánchez C
    Breast Cancer Res Treat; 2023 Jun; 199(2):363-370. PubMed ID: 36988750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.
    Senda N; Kawaguchi-Sakita N; Kawashima M; Inagaki-Kawata Y; Yoshida K; Takada M; Kataoka M; Torii M; Nishimura T; Kawaguchi K; Suzuki E; Kataoka Y; Matsumoto Y; Yoshibayashi H; Yamagami K; Tsuyuki S; Takahara S; Yamauchi A; Shinkura N; Kato H; Moriguchi Y; Okamura R; Kan N; Suwa H; Sakata S; Mashima S; Yotsumoto F; Tachibana T; Tanaka M; Togashi K; Haga H; Yamada T; Kosugi S; Inamoto T; Sugimoto M; Ogawa S; Toi M
    Cancer Sci; 2021 Aug; 112(8):3338-3348. PubMed ID: 34036661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program.
    Jones JC; Golafshar MA; Coston TW; Rao R; Wysokinska E; Johnson E; Esplin ED; Nussbaum RL; Heald B; Klint M; Barrus K; Uson PL; Nguyen CC; Colon-Otero G; Bekaii-Saab TS; Dronca R; Kunze KL; Samadder NJ
    Cureus; 2023 Apr; 15(4):e37428. PubMed ID: 37181954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline testing of
    Woodward ER; Lalloo F; Forde C; Pugh S; Burghel GJ; Schlecht H; Harkness EF; Howell A; Howell SJ; Gandhi A; Evans DG
    J Med Genet; 2024 Mar; 61(4):385-391. PubMed ID: 38123987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.
    Yadav S; Hu C; Hart SN; Boddicker N; Polley EC; Na J; Gnanaolivu R; Lee KY; Lindstrom T; Armasu S; Fitz-Gibbon P; Ghosh K; Stan DL; Pruthi S; Neal L; Sandhu N; Rhodes DJ; Klassen C; Peethambaram PP; Haddad TC; Olson JE; Hoskin TL; Goetz MP; Domchek SM; Boughey JC; Ruddy KJ; Couch FJ
    J Clin Oncol; 2020 May; 38(13):1409-1418. PubMed ID: 32125938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended gene panel testing in lobular breast cancer.
    van Veen EM; Evans DG; Harkness EF; Byers HJ; Ellingford JM; Woodward ER; Bowers NL; Wallace AJ; Howell SJ; Howell A; Lalloo F; Newman WG; Smith MJ
    Fam Cancer; 2022 Apr; 21(2):129-136. PubMed ID: 33763779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
    Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED
    Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.
    Abdel-Razeq H; Al-Azzam K; Elemian S; Abu-Fares H; Abu Sheikha A; Bani Hani H; Bater R; Sharaf B; Heald B; Esplin ED; Nielsen SM; Alkyam M; Abujamous L; Al-Attary A
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2125. PubMed ID: 36537080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
    Theobald KA; Susswein LR; Marshall ML; Roberts ME; Mester JL; Speyer D; Williams RNW; Knapke SC; Solomon SR; Murphy PD; Klein RT; Hruska KS; Solomon BD
    Ann Surg Oncol; 2018 Nov; 25(12):3556-3562. PubMed ID: 30167906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years.
    Desai NV; Yadav S; Batalini F; Couch FJ; Tung NM
    Cancer; 2021 Mar; 127(6):828-833. PubMed ID: 33146899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Genetic Testing in Unselected Squamous and Non-Squamous Head and Neck Cancers.
    Brake DA; Idler BM; Kunze KL; Golafshar MA; Heald B; Young S; Klint M; Barrus K; Esplin ED; Nussbaum RL; Samadder NJ; Hinni ML; Chang BA
    Laryngoscope; 2023 Dec; 133(12):3378-3388. PubMed ID: 37132629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care.
    De Silva DL; Stafford L; Skandarajah AR; Sinclair M; Devereux L; Hogg K; Kentwell M; Park A; Lal L; Zethoven M; Jayawardana MW; Chan F; Butow PN; James PA; Mann GB; Campbell IG; Lindeman GJ
    Med J Aust; 2023 May; 218(8):368-373. PubMed ID: 37005005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
    Bedrosian I; Somerfield MR; Achatz MI; Boughey JC; Curigliano G; Friedman S; Kohlmann WK; Kurian AW; Laronga C; Lynce F; Norquist BS; Plichta JK; Rodriguez P; Shah PD; Tischkowitz M; Wood M; Yadav S; Yao K; Robson ME
    J Clin Oncol; 2024 Feb; 42(5):584-604. PubMed ID: 38175972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.